Curis, Inc. (CRIS)

2d ago, source: Yahoo Finance

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on April 1, 2024, the independent ...

Curis Inc. Is Worried About This – Should You Be Worried Too?

2mon ago, source: Hosted on MSN

Curis Inc. (CRIS) has disclosed a new risk, in the Share Price & Shareholder Rights category. Curis Inc. recently underwent a 1-for-20 reverse stock split on September 28, 2023, which could ...

Curis, Inc. Common Stock (CRIS)

11y ago, source: Nasdaq

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...

Curis, Inc. (CRIS)

1d ago, source: Yahoo Finance

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on April 1, 2024, the independent ...

Curis Inc CUS0

9d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Curis, Inc. Common Stock (CRIS)

13y ago, source: Nasdaq

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Curis, Inc.

5mon ago, source: CNN

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 ...

Curis Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...